Skip to main content
SpringerLink
Log in

TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Arita H, Narita Y, Takami H et al (2013) TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomas. Acta Neuropathol 126:939–941. doi:10.1007/s00401-013-1203-9

    Article  PubMed  Google Scholar 

  2. Bibikova M, Barnes B, Tsan C et al (2011) High density DNA methylation array with single CpG site resolution. Genomics 98:288–295. doi:10.1016/j.ygeno.2011.07.007

    Article  CAS  PubMed  Google Scholar 

  3. Castelo-Branco P, Choufani S, Mack S et al (2013) Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study. Lancet Oncol 14:534–542. doi:10.1016/S1470-2045(13)70110-4

    Article  CAS  PubMed  Google Scholar 

  4. Hovestadt V, Remke M, Kool M et al (2013) Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays. Acta Neuropathol 125:913–916. doi:10.1007/s00401-013-1126-5

    Article  PubMed Central  PubMed  Google Scholar 

  5. Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA (2013) Highly recurrent TERT promoter mutations in human melanoma. Science (New York, NY) 339:957–959. doi:10.1126/science.1229259

    Article  CAS  Google Scholar 

  6. Killela PJ, Reitman ZJ, Jiao Y et al (2013) TERT promoter mutations occur frequently in gliomas and a subset of tumours derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA 110:6021–6026. doi:10.1073/pnas.1303607110

    Article  CAS  PubMed  Google Scholar 

  7. Koelsche C, Sahm F, Capper D et al (2013) Distribution of TERT promoter mutations in pediatric and adult tumours of the nervous system. Acta Neuropathol 126:907–915. doi:10.1007/s00401-013-1195-5

    Article  CAS  PubMed  Google Scholar 

  8. Northcott PA, Jones DT, Kool M et al (2012) Medulloblastomics: the end of the beginning. Nat Rev 12:818–834. doi:10.1038/nrc3410

    Article  CAS  Google Scholar 

  9. Remke M, Ramaswamy V, Peacock J et al (2013) TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol 126:917–929. doi:10.1007/s00401-013-1198-2

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Schwalbe EC, Williamson D, Lindsey JC et al (2013) DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Acta Neuropathol 125:359–371. doi:10.1007/s00401-012-1077-2

    Article  CAS  PubMed  Google Scholar 

  11. Taylor MD, Northcott PA, Korshunov A et al (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 123:465–472. doi:10.1007/s00401-011-0922-z

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

Funded by grants from The Brain Tumour Charity and Cancer Research UK. Tumours investigated include samples provided by the UK Children’s Cancer and Leukaemia Group (CCLG) as part of CCLG-approved biological study BS-2007-04. Conducted with ethics committee approval from Newcastle/North Tyneside REC (study reference 07/Q0905/71).

Author information

Authors and Affiliations

  1. Northern Institute for Cancer Research, Newcastle University, Royal Victoria Infirmary, Newcastle upon Tyne, UK

    Janet C. Lindsey, Ed. C. Schwalbe, Sandeep Potluri, Simon Bailey, Daniel Williamson & Steven C. Clifford

  2. Northern Institute for Cancer Research, Newcastle University, Sir James Spence Institute Level 5, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK

    Steven C. Clifford

Authors
  1. Janet C. Lindsey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ed. C. Schwalbe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sandeep Potluri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Simon Bailey
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daniel Williamson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Steven C. Clifford
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven C. Clifford.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 22 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lindsey, J.C., Schwalbe, E.C., Potluri, S. et al. TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours. Acta Neuropathol 127, 307–309 (2014). https://doi.org/10.1007/s00401-013-1225-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-013-1225-3

Keywords

Search

Navigation